Page 71 | Certara

Video

D360 Scientific Informatics Discovery Platform: User Stories

Transcript: I've joined companies both blueprint medicines and score therapeutics is one of the first…

CertaraFebruary 8, 2024

Press Coverage

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years,…

CertaraFebruary 8, 2024

Conference

Clinical Data Disclosure, Transparency & Plain Language Summaries 2024

CertaraFebruary 7, 2024

Conference

DIA MASC

CertaraFebruary 2, 2024

On-Demand Webinar

Drug Development’s New Model: Biosimulation from Discovery to Label Expansion

Key Highlights: How predictive technologies reshape drug development, mitigating project risks, navigating novel biomarkers, predicting…

CertaraFebruary 2, 2024

Press Release

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraFebruary 1, 2024

Conference

Phuse US Connect

Conference: Phuse US Connect Date: March 16-19, 2025 Location: Orlando, Florida Booth: A Sponsor: Platinum…

CertaraJanuary 31, 2024

Blog

Navigating Market Access for Healthcare Products: The Power of the Global Value Dossier

This blog defines the global value dossiers and explains how BaseCase can support creating interactive…

CertaraJanuary 24, 2024

On-Demand Webinar

Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products

Join us to understand the dynamics of the pharmaceutical market and learn how to maintain…

CertaraJanuary 24, 2024

Blog

Understanding the Role of Your Discovery Asset’s Target Product Profile

If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…

CertaraJanuary 19, 2024

D360 Scientific Informatics Discovery Platform: User Stories

Upping the Ante for Predicting the Success of Alzheimer Disease Treatments

Clinical Data Disclosure, Transparency & Plain Language Summaries 2024

DIA MASC

Drug Development’s New Model: Biosimulation from Discovery to Label Expansion

Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference

Phuse US Connect

Navigating Market Access for Healthcare Products: The Power of the Global Value Dossier

Navigating the “Patent Cliff”: Omni-channel Strategies for Loss of Exclusivity and Established Products

Understanding the Role of Your Discovery Asset’s Target Product Profile

Newsletter sign up

Quick links

Solutions

Contact